![Medicine / Chemistry / Osteopathies / Health / Osteoporosis / Etidronic acid / Aspirin / Denosumab / Bisphosphonates / Alendronic acid / Merck Medicine / Chemistry / Osteopathies / Health / Osteoporosis / Etidronic acid / Aspirin / Denosumab / Bisphosphonates / Alendronic acid / Merck](https://www.pdfsearch.io/img/8f0d19b48685aaed039f1db8e7c5dfe1.jpg)
| Document Date: 2011-07-06 13:23:05 Open Document File Size: 176,78 KBShare Result on Facebook
City Alendronate / / Company AEs / / Country United States / United Kingdom / Czech Republic / / Event FDA Phase / / IndustryTerm pharmaceutical formulation / clinical study protocol / alendronate containing products / treatment of osteoporosis / parallel / medicinal products / food / / MedicalCondition chronic pain / glucocorticoid-induced osteoporosis / GI disorders / nephritis / limb deformity / postmenopausal osteoporosis / bone disease / pain / osteomalacia / osteoporosis / paediatric osteoporosis / Osteogenesis imperfecta / osteoclastic bone resorption / skeletal disorders / bone resorption / steroid-induced osteoporosis / disorders / / MedicalTreatment surgery / / Organization FDA / European Union / / Person Shirley Norton / / Position investigator / EXECUTIVE / / Product Fosamax / Dronal Tablets / ALENDRONATE SODIUM / Drugs affecting bone metabolism Bisphosphonate M05BA04 Tablets / alendronate / / Technology study Protocol / pharmacokinetics / radiation / crystallization / clinical study protocol / clinical studies Protocol / clinical adverse experience Protocol / /
SocialTag |